Yahoo
OTC Markets OTCQX - Delayed Quote USD

Vext Science, Inc. (VEXTF)

0.1816 +0.0115 (+6.77%)
As of October 29 at 4:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for VEXTF
  • Previous Close 0.1700
  • Open 0.1776
  • Bid 0.1698 x 6000000
  • Ask 0.1835 x 2500000
  • Day's Range 0.1776 - 0.1776
  • 52 Week Range 0.1000 - 0.2850
  • Volume 5,000
  • Avg. Volume 26,325
  • Market Cap (intraday) 44.976M
  • Beta (5Y Monthly) 0.89
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 0.60

Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona.

vextscience.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

VEXTF
0.09%
S&P/TSX Composite index (^GSPTSE)
11.29%

1-Year Return

VEXTF
11.43%
S&P/TSX Composite index (^GSPTSE)
17.51%

3-Year Return

VEXTF
11.90%
S&P/TSX Composite index (^GSPTSE)
88.07%

5-Year Return

VEXTF
70.09%
S&P/TSX Composite index (^GSPTSE)
68.58%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 12.12M
Earnings -315k
Profit Margin -2.60%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-10M
-5M
0
5M
10M
-60.0%
-40.0%
-20.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

0.60
0.60 Average
0.1816 Current
0.60 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.39%

  • Return on Assets (ttm)

    -1.82%

  • Return on Equity (ttm)

    -22.98%

  • Revenue (ttm)

    50.68M

  • Net Income Avi to Common (ttm)

    -14.39M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.54M

  • Total Debt/Equity (mrq)

    62.33%

  • Levered Free Cash Flow (ttm)

    1.94M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: